United States - English - NLM (National Library of Medicine)

avpak - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil (mmf) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see clinical studies ( 14.1)], heart [see clinical studies ( 14.2)] or liver transplants [see clinical studies ( 14.3)] , in combination with other immunosuppressants. allergic reactions to mycophenolate mofetil have been observed; therefore, mycophenolate mofetil is contraindicated in patients with a hypersensitivity to mycophenolate mofetil (mmf), mycophenolic acid (mpa) or any component of the drug product. mycophenolate mofetil intravenous is contraindicated in patients who are allergic to polysorbate 80 (tween). pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to mycophenolate during pregnancy and those becoming pregnant within 6 weeks of discontinuing my

United States - English - NLM (National Library of Medicine)

avpak - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil 500 mg

European Union - English - EMA (European Medicines Agency)

biomarin international limited - sapropterin dihydrochloride - phenylketonurias - other alimentary tract and metabolism products, - kuvan is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment.kuvan is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

melrose laboratories pty ltd - glucosamine hydrochloride, quantity: 750 mg - capsule, hard - excipient ingredients: magnesium stearate; silicon dioxide; ascorbic acid; calcium hydrogen phosphate dihydrate; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum - decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; helps maintain/supports healthy joint cartilage growth/development/production ; maintain/support joint health ; decrease/reduce/relieve mild joint inflammation/swelling

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - lansoprazole - orodispersible tablet - 15 milligram(s) - proton pump inhibitors; lansoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - lansoprazole - orodispersible tablet - 15 milligram(s) - proton pump inhibitors; lansoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - mirtazapine - orodispersible tablet - 15 milligram(s) - other antidepressants; mirtazapine

Ireland - English - HPRA (Health Products Regulatory Authority)

bluefish pharmaceuticals ab - mirtazapine - orodispersible tablet - 15 milligram(s) - other antidepressants; mirtazapine

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - mirtazapine - orodispersible tablet - 15 milligram(s) - other antidepressants; mirtazapine

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - lansoprazole - orodispersible tablet - 15 milligram(s) - proton pump inhibitors; lansoprazole